Gilead Sciences Inc (GILD)

65.77 -1.86  -2.75% NASDAQ Dec 13, 20:00 Delayed 2m USD

Gilead Sciences Cash from Financing (TTM):

-8.408B for Sept. 30, 2019
View 4,000+ financial data types
Browse...
View Full Chart

Cash from Financing (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Financing (TTM) Data

View and export this data going back to 1990. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2019 -8.408B
June 30, 2019 -8.794B
March 31, 2019 -8.089B
Dec. 31, 2018 -12.32B
Sept. 30, 2018 -7.301B
June 30, 2018 -2.23B
March 31, 2018 -1.958B
Dec. 31, 2017 3.393B
Sept. 30, 2017 -2.302B
June 30, 2017 -1.675B
March 31, 2017 -2.356B
Dec. 31, 2016 -9.725B
Sept. 30, 2016 -11.84B
June 30, 2016 -7.995B
March 31, 2016 -11.78B
Dec. 31, 2015 -5.884B
Sept. 30, 2015 -185.00M
June 30, 2015 -12.60B
March 31, 2015 -8.631B
Dec. 31, 2014 -3.025B
Sept. 30, 2014 -5.104B
June 30, 2014 -274.35M
March 31, 2014 539.00M
Dec. 31, 2013 -2.544B
Sept. 30, 2013 -2.209B
   
June 30, 2013 -1.574B
March 31, 2013 -1.492B
Dec. 31, 2012 563.00M
Sept. 30, 2012 4.600B
June 30, 2012 4.031B
March 31, 2012 3.134B
Dec. 31, 2011 1.764B
Sept. 30, 2011 -2.223B
June 30, 2011 -1.076B
March 31, 2011 -869.63M
Dec. 31, 2010 -1.339B
Sept. 30, 2010 -1.203B
June 30, 2010 -1.899B
March 31, 2010 -889.66M
Dec. 31, 2009 -1.051B
Sept. 30, 2009 -1.314B
June 30, 2009 -1.023B
March 31, 2009 -930.59M
Dec. 31, 2008 -1.475B
Sept. 30, 2008 -872.34M
June 30, 2008 -683.70M
March 31, 2008 -975.24M
Dec. 31, 2007 -267.30M
Sept. 30, 2007 -263.21M
June 30, 2007 -302.30M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Financing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
Learn More

Advertisement

Cash from Financing (TTM) Benchmarks

Benchmarks
Amgen Inc -17.41B
Biogen Inc -5.181B
Johnson & Johnson -20.33B

Cash from Financing (TTM) Range, Past 5 Years

Minimum -12.60B Jun 2015
Maximum 3.393B Dec 2017
Average -6.185B
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.